Charles River Laboratories International (MIL:1CRL) Market Cap: €7,153 Mil (As of Jul. 05, 2026)


MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
70 GF Score
Price €143.90
GF Value €121.29
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Market Cap?

Charles River Laboratories International MIL:1CRL 70 Market Cap is €7,153 Mil as of Jul. 05, 2026. GuruFocus rates MIL:1CRL with a GF Score™ of 70/100 and a GF Value™ of €121.29. The stock has 8 warning signs investors should review. Among 219 Medical Diagnostics & Research companies, Charles River Laboratories International ranks better than 91.32% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Charles River Laboratories International's share price for the quarter that ended in Mar. 2026 was €0. Charles River Laboratories International's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 49 Mil. Therefore, Charles River Laboratories International's market cap for the quarter that ended in Mar. 2026 was €0 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Charles River Laboratories International's Enterprise Value for Today is €9,292 Mil.


Charles River Laboratories International  (MIL:1CRL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Charles River Laboratories International Market Cap Related Terms


Charles River Laboratories International Market Cap Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Market Cap Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MIL:1CRL vs RVTY, QGEN, ICLR: Market Cap Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International Market Cap vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Market Cap distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Market Cap falls into.


MIL:1CRL
70GF Score
Charles River Laboratories International Inc MIL:1CRL
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Charles River Laboratories International's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€0*49.215
=

Charles River Laboratories International's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€0*49.215
=€0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €7,153 Mil mean?
Charles River Laboratories International (MIL:1CRL) has a Market Cap of €7,153 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Charles River Laboratories International and its competitors. According to the industry distribution chart, Charles River Laboratories International ranks #19 out of 219 companies in the Medical Diagnostics & Research industry, placing it in the top 8.7%.
Is Charles River Laboratories International's Market Cap too high?
Charles River Laboratories International's current Market Cap is €7,153 Mil. Based on the distribution chart, Charles River Laboratories International ranks #19 out of 219 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Market Cap compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #19 out of 219 companies for Market Cap. This places Charles River Laboratories International in the top 9% of its industry — outperforming the majority of peers. The industry median Market Cap is 59.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 59.06, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Charles River Laboratories International and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 59.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charles River Laboratories International's current Market Cap is €7,153 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Market Cap of €7,153 Mil. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Market Cap is €7,153 Mil. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Market Cap is €7,153 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.

Key valuation signals for MIL:1CRL:

  • Market Cap: €7,153 Mil
  • GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score

Get the complete analysis for MIL:1CRL

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€121.29
GF Value